体力活动对2型糖尿病预防的影响:糖尿病预防计划的证据与经验
基于糖尿病预防计划(DPP)长期随访,分析3232名参与者每年自我报告的体力活动(PA)及1793人随机化后11-13年的加速度计数据。混合模型显示生活方式组PA累积量高于二甲双胍和安慰剂组;Cox模型表明PA每增加6 MET-h/周,糖尿病发生率降低6%(HR 0.94,95%CI 0.92-0.96,P<0.001),基线低PA者效果更显著(降低12%)。
要点
- PA每增加6 MET-h/周,糖尿病风险降低6%,独立于体重变化。
- 基线PA低于7.5 MET-h/周者获益更大,风险降低12%。
- 生活方式干预组长期PA水平高于二甲双胍和安慰剂组。
核心结论
- 在整个队列中,体力活动与糖尿病发病率呈负相关,加速度计横断面结果支持该发现。
- 生活方式干预中体力活动对预防糖尿病具有重要作用,咨询高风险患者时应同时考虑体力活动和体重。
研究设计与样本
- 糖尿病预防计划(DPP)长期随访研究,纳入3232名参与者,其中1793人在随机化后11-13年完成一次加速度计评估。
- 每年收集自我报告的体力活动和糖尿病评估,每半年检测空腹血糖,必要时行口服葡萄糖耐量试验。
主要发现
- 整个队列平均随访12年,时间依赖性PA每增加6 MET-h/周,糖尿病发生率降低6%(Cox风险比0.94,95%CI 0.92-0.96,P<0.001),控制年龄、性别、基线PA和体重。
- 基线PA低于7.5 MET-h/周者(n=1338)PA每增加6 MET-h/周,糖尿病风险降低12%(HR 0.88,95%CI 0.83-0.93,P<0.0001),生活方式组中更显著。
- 生活方式组累积PA高于二甲双胍或安慰剂组(P<0.0001),随访期间加速度计每日总分钟数也更高(P=0.001和P=0.047)。
- 所有关联在模型中额外调整体重后仍显著。
临床怎么用
- 在生活方式干预中应强调体力活动对预防糖尿病的重要性。
- 对高风险患者进行咨询时,需同时关注体力活动和体重。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Across the Diabetes Prevention Program (DPP) follow-up, cumulative diabetes incidence remained lower in the lifestyle compared with the placebo and metformin randomized groups and could not be explained by weight. Collection of self-reported physical activity (PA) (yearly) with cross-sectional objective PA (in follow-up) allowed for examination of PA and its long-term impact on diabetes prevention. RESEARCH DESIGN AND METHODS: Yearly self-reported PA and diabetes assessment and oral glucose tolerance test results (fasting glucose semiannually) were collected for 3,232 participants with one accelerometry assessment 11-13 years after randomization (n = 1,793). Mixed models determined PA differences across treatment groups. The association between PA and diabetes incidence was examined using Cox proportional hazards models. RESULTS: There was a 6% decrease (Cox proportional hazard ratio 0.94 [95% CI 0.92, 0.96]; P < 0.001) in diabetes incidence per 6 MET-h/week increase in time-dependent PA for the entire cohort over an average of 12 years (controlled for age, sex, baseline PA, and weight). The effect of PA was greater (12% decrease) among participants less active at baseline (<7.5 MET-h/week) (n = 1,338) (0.88 [0.83, 0.93]; P < 0.0001), with stronger findings for lifestyle participants. Lifestyle had higher cumulative PA compared with metformin or placebo (P < 0.0001) and higher accelerometry total minutes per day measured during follow-up (P = 0.001 and 0.047). All associations remained significant with the addition of weight in the models. CONCLUSIONS: PA was inversely related to incident diabetes in the entire cohort across the study, with cross-sectional accelerometry results supporting these findings. This highlights the importance of PA within lifestyle intervention efforts designed to prevent diabetes and urges health care providers to consider both PA and weight when counseling high-risk patients.
引用
- Kriska AM, Rockette-Wagner B, Edelstein SL, et al. The Impact of Physical Activity on the Prevention of Type 2 Diabetes: Evidence and Lessons Learned From the Diabetes Prevention Program, a Long-Standing Clinical Trial Incorporating Subjective and Objective Activity Measures. Diabetes Care. 2020. PMID: 33444158. doi:10.2337/dc20-1129
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。